Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You're welcome. Anytime.
"I never thought penny stocks, particularly DNAG, are capable of being meaningfully analyzed from a technical standpoint because of their unpredictability and volatility"
LOL. Support is support. And resistance is resistance. No matter what the pps is. So I guess you didn't know to buy DNAG when it dipped below the lower bolli huh. Too bad.
Good luck Frud.
You're right, the pps is of main importsnce here. That's why I bought it- it's cheap. Really cheap. Market cap only 3mil? lol
"synonymous with genetic etc.." I meant in the public eye. Isn't that what matters? Lot's of free advertising going on lately .. refer to news over last few weeks, and months (but particulary last few weeks)
Mostly frud I am a chartist, not an analyst. Chart looks ready to go .. making significant moves here this week technically. I also find it interesting that we popped up in percentage on three times avg trading volume the day after this report was released...
Standard & Poor's Stock Reports
DNAPRINT GENOMICS INC (NASDAQ:DNAG)
Detail of reports available for DNAPRINT GENOMICS INC:
Earnings and Recommendations News Mon Feb 6 07:42:00 CST 2006
Industry Outlook Mon Feb 6 07:42:00 CST 2006
for you darcy ..
Stocks covered throughout the Traders Nation show on 02.07.06 include: DNAPrint genomics, Inc. (OTCBB:DNAG), Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), Earth Biofuels, Incorporated (OTCBB:EBOF), Produce Safety and Security International Inc (OTC:PDSC), Pet Ecology Brands, Inc. (OTC:PECB)
imo it just gets us one step closer to realizing goals of being a real pharm drug company.
http://www.tradersnation.com/proxstream.shtml
Stocks covered throughout the Traders Nation show on 02.07.06 include: DNAPrint genomics, Inc. (OTCBB:DNAG), Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), Earth
Biofuels, Incorporated (OTCBB:EBOF), Produce Safety and Security International
Inc (OTC:PDSC), Pet Ecology Brands, Inc. (OTC:PECB)
just what i was talking about. pharmeceuticals .. that's where it's at.
02/07/2006 (16:05 ET) DNAG: Filed New Form 8-K, Material Event Disclosure - Edgar
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3940066
remember folks ... the ancestry thing is only a third of what it is DNAG does ... personalized pharmaceuticals is where it's at, and that's where this company is going. This ancestry toy is just a way to get the word out.
if the management is so deficient here frud .. then how is it that the name DNAPrint is quickly becoming synonymous with genetic biotechnology ... which is the next BIG thing in biotechnology.
just starting imo
That was one of the craziest shakeouts I've ever witnessed. Climbed up 15% on HUGE volume then turned red on low volume, only to be brought right back on HUGE volume. Like .. one order of 800k at the ask to start. All in about 5min. Up from here folks imo. Hold on and enjoy the ride.
DNAG .0234 x .0235 7mil shares in last 20 min.
Dr. Frud ... time to cover.
DNAG .. anybody watching? Gonna fly imo.
I know yu guys don't like DNAG .. but watch.
500k at the ask
weeeeeeeeeeeee
I just realized the best part about reading through all the rants here ... are the images of all the realy hot chicks! Keep ranting guys.
Jim, I really hope all your bashing here has the same affect as it did with MLON.
lol, many
Richard Stone, President of Trajectory Sports & Media Group, LLC
January 30, 2006 - We recently announced that Trajectory Sports has been retained by The Fight Network (www.thefightnetwork.com) to assist them with the launch of their channel in the United States and other markets.
note: "to assist them with the launch" not "help them try and launch"
link to rest of letter-
http://www.trajectorysports.com/letter_from.html
i find it hard to believe that many flippers here have made money in this stock recently. (i could be wrong of course) But those buying, and averaging, and holding, will do well, thus the congrats.
From the little bit of DD I've done on this stock- it is just not in the cards that we don't get picked up by U.S carriers- americans love a good fight- flippers/I'm sorry- investors/congrats. Long and strong here ... sell to me please.
he could have gotten his GED by now with all the time he spends on this board bashing. lol
DNAG Chart ... attention ... now trading above 100dma ... first time in six months.
Yes ... a nice base indeed.
All indicators pointing north.
Enjoy.
http://stockcharts.com/def/servlet/SC.web?c=DNAG,uu[e,a]daclyyay[dc][pb50!b100!d20,2!h.02,.20][vc60]...
charts=crystal ball
charts speak louder than words, and filings.
remember this? from 9/04
SARASOTA, Fla., Sept. 28 /PRNewswire-FirstCall/ -- DNAPrint(TM) genomics,
Inc. (OTC Bulletin Board: DNAP) today announced that it has agreed to acquire
a 51.77% stake in German pharmaceutical company Biofrontera AG. DNAPrint
simultaneously announced that it has received a commitment from Dutchess
Private Equities Fund, L.P. to purchase up to $35 million in DNAPrint common
stock over the next two years.
DNAPrint has agreed to invest 20 million euro (approximately $25.00
million) over 24 months in Biofrontera Series B preferred shares (68% of B
shares) representing a 51.77% equity interest. Biofrontera will use the
proceeds of the investment to advance its clinical and preclinical drug
pipeline. DNAPrint is only obligated to close the transaction and to begin
paying the purchase price for the Biofrontera shares after it begins making
sales of common stock under its arrangement with Dutchess.
DNAPrint will participate in a clinical pipeline of novel drugs, as well
as an extensive pre-clinical compound portfolio and a broad technology base.
This strategic investment will form the basis of future joint ventures between
the two companies, expanding DNAPrint's presence in Europe and giving
Biofrontera a presence in North America. DNAPrint and Biofrontera have signed
a joint venture framework agreement designed to integrate the companies'
technologies in a mutually beneficial way.
The acquisition will transform DNAPrint from a population genomics company
into a genomics based pharmaceutical company devoted to the development of
21st century "Theranostics" products. "Theranostics" blend genomics-based
tests with drugs as products to target segments of the patient population for
enhanced efficacy and reduced side effects. Management expects the use of
genome-based testing to facilitate the drug development process and accelerate
selected drugs through the clinical trial process. Both DNAPrint and
Biofrontera believe that Theranostics will form the foundation for post-
genome, 21st century medical care.
Biofrontera's lead product candidate, BF-Derm1, is currently in phase II
clinical trials for the treatment of severe, antihistamine-refractory chronic
Urticaria or chronic itching and scratching. The first interim report of a
European adaptive phase II clinical trial recently indicated that the compound
exhibited a 40% improvement above placebo in clinical symptoms. Biofrontera
has also advanced a novel prophylactic migraine treatment to pre-clinical
development, and has a series of other compounds at the pre-clinical stage.
Professor Doctor Hermann Luebbert, CEO of Biofrontera AG, will join the
DNAPrint board of directors.
DNAPrint also has entered into an Investment Agreement with Dutchess
Private Equities Fund. Dutchess will purchase common stock from DNAPrint, at
times and in amounts selected by DNAPrint, up to a total investment of
$35 million over the next two years. The purchase price at which Dutchess
will purchase DNAPrint's stock is based on the trading price of the stock, and
the funding will begin after DNAPrint registers the common stock that it will
issue in the transaction. DNAPrint anticipates that the transaction will
provide it with equity to build the business of the two companies. The
commitment was arranged by Athena Capital Partners.
"We are extremely excited about the alliance between DNAPrint(TM) and
Biofrontera, and we believe we have established a reliable and trustworthy
source of capital for development of both companies," said Richard Gabriel,
CEO and President of DNAPrint. "Our goal for this financing, once it is
completed through the registration process, is to build shareholder value
beyond the inherent investment value that Biofrontera brings to the
relationship. The investment brings Biofrontera's value to over $51 million,
and we fully expect that value to increase for our shareholders if Biofrontera
strikes its milestones. We hope to increase our revenues by combining the
distinct businesses of the two companies and by offering services that address
many of the problems in drug discovery and development. By paying for the
Biofrontera shares over time we have a unique opportunity to achieve our
mutual goals and objectives."
I hope I am right too. But I agree .. a mention in newsweek article doesn't equal earnings .. so it's not the nuts ... but tecnically speaking, it did put us where we needed to be (on the chart) to press upwards. FWIW. Good Luck.
bashers can talk all they want here ... charts speak louder than words ... today broke all kinds of resistance ... crossed above the 50 and the 100dma ... broke the upper bolli ... and the pattern of the last three weeks is identical to that of late Oct'05(just before the boom) ... can you say article in Newsweek? How about imminent buyin? Momentum? HOD Close? I'm holding. GLTY
Hey EZ ... how about a chart for DNAG. Looks sweet. Today it crossed above the 50dma and 100dma and closed at HOD. Just FYI.
DNAG- stong close - will run next week.
PTSC- back in play.
GLIF- nice close.
MSEP- anxious to see what comes of this.
BKMP- holding out for the big day.
CYOS- nice bounce from below lower bolli- one to watch imo.
GLTA, many
Can GLIF close green? Yes.
Sorry .. AT the ask ... still nice
GLIF 300k above the ask?
Where is this MSEP headed?
PTSC Watch It!
ivoc looks like a runner
ewu ... your picks seem to be panning out nicely .. I'm sorry I ever doubted your motives here. Happy trading.
DNAG Double Whammy.
News and imminent buyin warning on same morning.
02/03/2006 (09:40 ET) BUYINS.NET: CMED, CRF, IFO, ABFIQ, ATAHQ, DNAG have been on BUYINS.NET naked short list for 13 consecutive trading days -
GLIF looking solid.
DNAG, check out the volume bars on the hourly chart .. crazy.
dnag, good momo, tight spread